Skip to content

Evaluation of the effectiveness of Vitamin E in patients with myocardial infarction

Evaluation of the effectiveness of Vitamin E on the high-sensitivity C-reactive protein (hs-CRP) level in patients with myocardial infarction

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250827067025N1
Enrollment
72
Registered
2025-09-14
Start date
2025-09-23
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial Infarction. ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction

Interventions

Intervention 1: Intervention group: In the intervention group, patients with myocardial infarction who receive treatment with vitamin E capsules at a dose of 200 mg once a day in addition to standard

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with myocardial infarction according to the American College of Cardiology criteria Consent to enter the study Age over 18 years Not suffering from kidney failure under hemodialysis Absence of kidney failure and GFR<30 Absence of severe liver failure with liver enzymes more than 3 times normal Not taking Vitamin E

Exclusion criteria

Exclusion criteria: Lack of consent to continue studying

Design outcomes

Primary

MeasureTime frame
Changes in hs-CRP serum levels. Timepoint: At the beginning of the study and after 4 weeks of treatment. Method of measurement: Laboratory kit.

Secondary

MeasureTime frame
Lipid profile changes. Timepoint: At the beginning of the study and after 4 weeks of treatment. Method of measurement: Laboratory kit.;CBC level changes diff. Timepoint: At the beginning of the study and after 4 weeks of treatment. Method of measurement: Laboratory kit.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMostafa Ahmadi

Mashhad University of Medical Sciences

mostafaahmadi1975@gmail.com0985138012739

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026